GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Tianyao Pharmaceutical Co Ltd (SHSE:600488) » Definitions » EV-to-Revenue

Tianjin Tianyao Pharmaceutical Co (SHSE:600488) EV-to-Revenue : 1.19 (As of Apr. 28, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Tianyao Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Tianjin Tianyao Pharmaceutical Co's enterprise value is ¥4,510 Mil. Tianjin Tianyao Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ¥3,783 Mil. Therefore, Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue for today is 1.19.

The historical rank and industry rank for Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

SHSE:600488' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.32   Med: 2.34   Max: 8.77
Current: 1.19

During the past 13 years, the highest EV-to-Revenue of Tianjin Tianyao Pharmaceutical Co was 8.77. The lowest was 1.32. And the median was 2.34.

SHSE:600488's EV-to-Revenue is ranked better than
74.85% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs SHSE:600488: 1.19

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-28), Tianjin Tianyao Pharmaceutical Co's stock price is ¥3.91. Tianjin Tianyao Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥3.46. Therefore, Tianjin Tianyao Pharmaceutical Co's PS Ratio for today is 1.13.


Tianjin Tianyao Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Tianyao Pharmaceutical Co EV-to-Revenue Chart

Tianjin Tianyao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 2.31 1.88 1.73 1.69

Tianjin Tianyao Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 1.67 1.94 1.82 1.69

Competitive Comparison of Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue falls into.



Tianjin Tianyao Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4510.378/3782.827
=1.19

Tianjin Tianyao Pharmaceutical Co's current Enterprise Value is ¥4,510 Mil.
Tianjin Tianyao Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,783 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Tianyao Pharmaceutical Co  (SHSE:600488) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Tianjin Tianyao Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=3.91/3.458
=1.13

Tianjin Tianyao Pharmaceutical Co's share price for today is ¥3.91.
Tianjin Tianyao Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.46.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Tianyao Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tianjin Tianyao Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Business Description

Traded in Other Exchanges
N/A
Address
No. 109 Bawei Road, Hedong District, Tianjin, Tianjin, CHN, 300171
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.

Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Headlines

No Headlines